Works matching AU Gold, Mark S.

Results: 163
    1
    2
    3
    4

    Can Drug Design Inhibit Abuse?

    Published in:
    Journal of Psychoactive Drugs, 2005, v. 37, n. 4, p. 343, doi. 10.1080/02791072.2005.10399808
    By:
    • Coleman, John J.;
    • Bensinger, Peter B.;
    • Gold, Mark S.;
    • Smith, David E.;
    • Bianchi, Robert P.;
    • Dupont, Robert L.
    Publication type:
    Article
    5
    6

    Drugs.

    Published in:
    2002
    By:
    • Gold, Mark S.;
    • Frost-Pineda, Kim
    Publication type:
    Book Review
    7
    8
    9

    Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?

    Published in:
    International Journal of Environmental Research & Public Health, 2022, v. 19, n. 11, p. 6395, doi. 10.3390/ijerph19116395
    By:
    • Madigan, Margaret A.;
    • Gupta, Ashim;
    • Bowirrat, Abdalla;
    • Baron, David;
    • Badgaiyan, Rajendra D.;
    • Elman, Igor;
    • Dennen, Catherine A.;
    • Braverman, Eric R.;
    • Gold, Mark S.;
    • Blum, Kenneth
    Publication type:
    Article
    10

    Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".

    Published in:
    International Journal of Environmental Research & Public Health, 2022, v. 19, n. 9, p. 5480, doi. 10.3390/ijerph19095480
    By:
    • Braverman, Eric R.;
    • Dennen, Catherine A.;
    • Gold, Mark S.;
    • Bowirrat, Abdalla;
    • Gupta, Ashim;
    • Baron, David;
    • Roy, A. Kenison;
    • Smith, David E.;
    • Cadet, Jean Lud;
    • Blum, Kenneth
    Publication type:
    Article
    11

    Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors.

    Published in:
    International Journal of Environmental Research & Public Health, 2022, v. 19, n. 1, p. 552, doi. 10.3390/ijerph19010552
    By:
    • Gupta, Ashim;
    • Bowirrat, Abdalla;
    • Gomez, Luis Llanos;
    • Baron, David;
    • Elman, Igor;
    • Giordano, John;
    • Jalali, Rehan;
    • Badgaiyan, Rajendra D.;
    • Modestino, Edward J.;
    • Gold, Mark S.;
    • Braverman, Eric R.;
    • Bajaj, Anish;
    • Blum, Kenneth
    Publication type:
    Article
    12
    13

    Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

    Published in:
    International Journal of Environmental Research & Public Health, 2021, v. 18, n. 18, p. 9774, doi. 10.3390/ijerph18189774
    By:
    • Blum, Kenneth;
    • Gold, Mark S.;
    • Llanos-Gomez, Luis;
    • Jalali, Rehan;
    • Thanos, Panayotis K.;
    • Bowirrat, Abdalla;
    • Downs, William B.;
    • Bagchi, Debasis;
    • Braverman, Eric R.;
    • Baron, David;
    • Roy III, Alphonso Kenison;
    • Badgaiyan, Rajendra D.
    Publication type:
    Article
    14

    Altered functional brain networks in Prader-Willi syndrome.

    Published in:
    NMR in Biomedicine, 2013, v. 26, n. 6, p. 622, doi. 10.1002/nbm.2900
    By:
    • Zhang, Yi;
    • Zhao, Heng;
    • Qiu, Siyou;
    • Tian, Jie;
    • Wen, Xiaotong;
    • Miller, Jennifer L.;
    • Deneen, Karen M.;
    • Zhou, Zhenyu;
    • Gold, Mark S.;
    • Liu, Yijun
    Publication type:
    Article
    15

    Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

    Published in:
    Biomedicines, 2022, v. 10, n. 4, p. 870, doi. 10.3390/biomedicines10040870
    By:
    • Gondré-Lewis, Marjorie C.;
    • Elman, Igor;
    • Alim, Tanya;
    • Chapman, Edwin;
    • Settles-Reaves, Beverlyn;
    • Galvao, Carine;
    • Gold, Mark S.;
    • Baron, David;
    • Kazmi, Shan;
    • Gardner, Eliot;
    • Gupta, Ashim;
    • Dennen, Catherine;
    • Blum, Kenneth
    Publication type:
    Article
    16
    17

    Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms.

    Published in:
    Neuroscientist, 2022, v. 28, n. 6, p. 552, doi. 10.1177/1073858420984106
    By:
    • Haidar, Muhammad Ali;
    • Jourdi, Hussam;
    • Haj Hassan, Zeinab;
    • Ashekyan, Ohanes;
    • Fardoun, Manal;
    • Wehbe, Zena;
    • Maaliki, Dina;
    • Wehbe, Maya;
    • Mondello, Stefania;
    • Abdelhady, Samar;
    • Shahjouei, Shima;
    • Bizri, Maya;
    • Mechref, Yehia;
    • Gold, Mark S;
    • Dbaibo, Ghassan;
    • Zaraket, Hassan;
    • Eid, Ali H.;
    • Kobeissy, Firas
    Publication type:
    Article
    18

    Methamphetamine Causes Microglial Activation in the Brains of Human Abusers.

    Published in:
    Journal of Neuroscience, 2008, v. 28, n. 22, p. 5756, doi. 10.1523/JNEUROSCI.1179-08.2008
    By:
    • Sekine, Yoshimoto;
    • Ouchi, Yasuomi;
    • Sugihara, Genichi;
    • Takei, Nori;
    • Yoshikawa, Etsuji;
    • Nakamura, Kazuhiko;
    • Iwata, Yasuhide;
    • Tsuchiya, Kenji J.;
    • Suda, Shiro;
    • Suzuki, Katsuaki;
    • Kawai, Masayoshi;
    • Takebayashi, Kiyokazu;
    • Yamamoto, Shigeyuki;
    • Matsuzaki, Hideo;
    • Ueki, Takatoshi;
    • Mori, Norio;
    • Gold, Mark S.;
    • Cadet, Jean L.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24

    Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 2015, doi. 10.3390/jpm12122015
    By:
    • Ceccanti, Mauro;
    • Blum, Kenneth;
    • Bowirrat, Abdalla;
    • Dennen, Catherine A.;
    • Braverman, Eric R.;
    • Baron, David;
    • Mclaughlin, Thomas;
    • Giordano, John;
    • Gupta, Ashim;
    • Downs, Bernard W.;
    • Bagchi, Debasis;
    • Barh, Debmalya;
    • Elman, Igor;
    • Thanos, Panayotis K.;
    • Badgaiyan, Rajendra D.;
    • Edwards, Drew;
    • Gold, Mark S.
    Publication type:
    Article
    25

    Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 12, p. 1946, doi. 10.3390/jpm12121946
    By:
    • Modestino, Edward Justin;
    • Blum, Kenneth;
    • Dennen, Catherine A.;
    • Downs, B. William;
    • Bagchi, Debasis;
    • Llanos-Gomez, Luis;
    • Elman, Igor;
    • Baron, David;
    • Thanos, Panayotis K.;
    • Badgaiyan, Rajendra D.;
    • Braverman, Eric R.;
    • Gupta, Ashim;
    • Gold, Mark S.;
    • Bowirrat, Abdalla
    Publication type:
    Article
    26

    Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 11, p. 1864, doi. 10.3390/jpm12111864
    By:
    • Dennen, Catherine A.;
    • Blum, Kenneth;
    • Bowirrat, Abdalla;
    • Thanos, Panayotis K.;
    • Elman, Igor;
    • Ceccanti, Mauro;
    • Badgaiyan, Rajendra D.;
    • McLaughlin, Thomas;
    • Gupta, Ashim;
    • Bajaj, Anish;
    • Baron, David;
    • Downs, B. William;
    • Bagchi, Debasis;
    • Gold, Mark S.
    Publication type:
    Article
    27

    Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 11, p. 1772, doi. 10.3390/jpm12111772
    By:
    • Blum, Kenneth;
    • Han, David;
    • Bowirrat, Abdalla;
    • Downs, Bernard William;
    • Bagchi, Debasis;
    • Thanos, Panayotis K.;
    • Baron, David;
    • Braverman, Eric R.;
    • Dennen, Catherine A.;
    • Gupta, Ashim;
    • Elman, Igor;
    • Badgaiyan, Rajendra D.;
    • Llanos-Gomez, Luis;
    • Khalsa, Jag;
    • Barh, Debmalya;
    • McLaughlin, Thomas;
    • Gold, Mark S.
    Publication type:
    Article
    28

    Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 10, p. 1719, doi. 10.3390/jpm12101719
    By:
    • Blum, Kenneth;
    • Dennen, Catherine A.;
    • Elman, Igor;
    • Bowirrat, Abdalla;
    • Thanos, Panayotis K.;
    • Badgaiyan, Rajendra D.;
    • Downs, B. William;
    • Bagchi, Debasis;
    • Baron, David;
    • Braverman, Eric R.;
    • Gupta, Ashim;
    • Green, Richard;
    • McLaughlin, Thomas;
    • Barh, Debmalya;
    • Gold, Mark S.
    Publication type:
    Article
    29

    Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 9, p. N.PAG, doi. 10.3390/jpm12091385
    By:
    • Blum, Kenneth;
    • Han, David;
    • Gupta, Ashim;
    • Baron, David;
    • Braverman, Eric R.;
    • Dennen, Catherine A.;
    • Kazmi, Shan;
    • Llanos-Gomez, Luis;
    • Badgaiyan, Rajendra D.;
    • Elman, Igor;
    • Thanos, Panayotis K.;
    • Downs, Bill W.;
    • Bagchi, Debasis;
    • Gondre-Lewis, Marjorie C.;
    • Gold, Mark S.;
    • Bowirrat, Abdalla
    Publication type:
    Article
    30

    Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation.

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 1009, doi. 10.3390/jpm12061009
    By:
    • Blum, Kenneth;
    • Brodie, Mark S.;
    • Pandey, Subhash C.;
    • Cadet, Jean Lud;
    • Gupta, Ashim;
    • Elman, Igor;
    • Thanos, Panayotis K.;
    • Gondre-Lewis, Marjorie C.;
    • Baron, David;
    • Kazmi, Shan;
    • Bowirrat, Abdalla;
    • Febo, Marcelo;
    • Badgaiyan, Rajendra D.;
    • Braverman, Eric R.;
    • Dennen, Catherine A.;
    • Gold, Mark S.
    Publication type:
    Article
    31

    Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020321
    By:
    • Blum, Kenneth;
    • McLaughlin, Thomas;
    • Bowirrat, Abdalla;
    • Modestino, Edward J.;
    • Baron, David;
    • Gomez, Luis Llanos;
    • Ceccanti, Mauro;
    • Braverman, Eric R.;
    • Thanos, Panayotis K.;
    • Cadet, Jean Lud;
    • Elman, Igor;
    • Badgaiyan, Rajendra D.;
    • Jalali, Rehan;
    • Green, Richard;
    • Simpatico, Thomas A.;
    • Gupta, Ashim;
    • Gold, Mark S.
    Publication type:
    Article
    32

    A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.

    Published in:
    Journal of Personalized Medicine, 2021, v. 11, n. 3, p. 212, doi. 10.3390/jpm11030212
    By:
    • Blum, Kenneth;
    • Kazmi, Shan;
    • Modestino, Edward J.;
    • Downs, Bill William;
    • Bagchi, Debasis;
    • Baron, David;
    • McLaughlin, Thomas;
    • Green, Richard;
    • Jalali, Rehan;
    • Thanos, Panayotis K.;
    • Elman, Igor;
    • Badgaiyan, Rajendra D.;
    • Bowirrat, Abdalla;
    • Gold, Mark S.;
    • Lee, Su-Jun;
    • Leporatti, Stefano
    Publication type:
    Article
    33

    “Antianxiety and opiates”.

    Published in:
    Behavioral & Brain Sciences, 1982, v. 5, n. 3, p. 486, doi. 10.1017/S0140525X00013108
    By:
    • Gold, Mark S.;
    • Fox, Corinne Frantz
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Chronic Methamphetamine Effects on Brain Structure and Function in Rats.

    Published in:
    PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0155457
    By:
    • Thanos, Panayotis K.;
    • Kim, Ronald;
    • Delis, Foteini;
    • Ananth, Mala;
    • Chachati, George;
    • Rocco, Mark J.;
    • Masad, Ihssan;
    • Muniz, Jose A.;
    • Grant, Samuel C.;
    • Gold, Mark S.;
    • Cadet, Jean Lud;
    • Volkow, Nora D.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50